Magda Šišková

Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow

Anna Jonášová, R Neuwírtová, Jaroslav Čermák et al. · British Journal of Haematology · 1998 · 212 citations

Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome

Božena Novotná, Yana Bagryantseva, Magda Šišková et al. · Leukemia Research · 2008 · 45 citations

Hematological Malignancy, Chromatin, Dna Damage +14

Prognostic significance of del(20q) in patients with hematological malignancies

Jana Březinová, Zuzana Zemanová, Šárka Ransdorfová et al. · Cancer Genetics and Cytogenetics · 2005 · 34 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +5

Efficacy And Safety Of Administration Of Oral Iron Chelator Deferiprone In Patients With Early Myelodysplastic Syndrome

Jaroslav Čermák, Anna Jonášová, Jana Vondráková et al. · Hemoglobin · 2011 · 34 citations

Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes

Karla Svobodová, Zuzana Zemanová, Halka Lhotská et al. · Leukemia Research · 2016 · 32 citations

Hematological Malignancy, Homozygous Mutations, Genome Instability +10